Epidermolysis Bullosa Simplex
📧 Sign up to get email alerts when something new happens for Epidermolysis Bullosa Simplex.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS) [Phase 2, Phase 3]
An international, multicenter Phase 2/3 randomized, double-blind, parallel-group, vehicle-controlled study is evaluating the efficacy and sa…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized [Phase 2]
A Phase 2 trial assessing apremilast for Epidermolysis Bullosa Simplex is currently recruiting at Centre Hospitalier Universitaire de Nice.
-
CLINICAL_TRIALS trial_result · 2023-08-23Clinical Trial Update: Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex [Phase 2, Phase 3]
Clinical trial update for botulinic toxin injections in plantar lesions of Epidermolysis Bullosa Simplex across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa [Phase 2]
Phase 2 clinical trial of INM-755 (cannabinol) cream for epidermolysis bullosa has completed.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex [Phase 2]
Phase 2 long-term open-label study evaluating the safety of diacerein 1% ointment topical formulation in epidermolysis bullosa simplex.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB) [Phase 1]
Phase 1 pharmacokinetic study evaluating diacerein and rhein after maximum use in patients with epidermolysis bullosa, completed with result…
-
CLINICAL_TRIALS trial_result · 2020-01-30Clinical Trial Update: Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study [Phase 2]
Phase 2 trial investigating topical sirolimus 2% for Epidermolysis Bullosa Simplex and related conditions has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-05Clinical Trial Update: Safety and Efficacy of Diacerein 1% Ointment for Subjects With Epidermolysis Bullosa Simplex (EBS) [Phase 2]
Phase 2 clinical trial of 1% diacerein ointment for epidermolysis bullosa simplex was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin [Phase 1]
A Phase 1 trial funded by Johns Hopkins University evaluating whether broccoli sprout extract affects keratinocyte differentiation in normal…
-
CLINICAL_TRIALS trial_result · 2017-10-24Clinical Trial Update: Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study [Phase 2]
Phase 2 clinical trial update evaluating topical sirolimus 2% for patients with epidermolysis bullosa simplex.
-
CLINICAL_TRIALS trial_result · 2011-10-14Clinical Trial Update: Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral Erythromycin [Phase 3]
A Phase 3 clinical trial is evaluating oral erythromycin for the Dowling-Meara type Epidermolysis Bullosa Simplex.